News from the partners – archive
https://amr-accelerator.eu/wp-content/uploads/2023/07/AMR-Accelerator_partner_news_2024-1.png
943
943
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2023-07-25 15:17:372024-04-23 13:59:3225/07/23 – UKHSA launches new strategy to tackle national and global health hazards
https://amr-accelerator.eu/wp-content/uploads/2024/04/AMR-Accelerator_partner_news_2024-2.png
943
943
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2023-06-28 15:47:432024-04-08 15:48:1028/06/23 – Small particles will deliver TB drugs to the lungs in the future
https://amr-accelerator.eu/wp-content/uploads/2023/01/Nosopharm.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2023-01-25 14:20:042023-07-28 14:50:0625/01/23 – Worm-associated bacteria are an untapped source of antibiotics
https://amr-accelerator.eu/wp-content/uploads/2023/01/HIPS.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2023-01-23 14:18:192023-07-28 14:50:4623/01/23 – Saarbrücken researchers use bacterial communication as a target for new drugs
https://amr-accelerator.eu/wp-content/uploads/2019/05/Unbenannt18-e1580379932190.png
495
495
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2023-01-18 14:26:332023-07-28 14:37:3918/01/23 – ENABLE-2 Open Call raising international interest
https://amr-accelerator.eu/wp-content/uploads/2022/08/SSI.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-08-30 14:14:062023-07-28 14:51:5230/08/22 – Danish Minister for Health visits the International Vaccine Institute during official visit to Republic of Korea
https://amr-accelerator.eu/wp-content/uploads/2022/01/Partner_PrIMAVeRa_0000_ares.jpg
500
500
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-07-26 14:06:272023-07-28 14:06:3726/07/22 – OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
https://amr-accelerator.eu/wp-content/uploads/2022/07/Evotec.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-07-06 14:09:282023-07-28 14:53:2106/07/22 – Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
https://amr-accelerator.eu/wp-content/uploads/2022/04/NICE.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-04-12 13:56:112023-07-28 14:54:0512/04/22 – NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance
https://amr-accelerator.eu/wp-content/uploads/2022/03/Uni-Dundee.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-03-04 14:00:462023-07-28 14:54:4224/03/22 – Post-Covid TB warning as DDU receives $5 million award
https://amr-accelerator.eu/wp-content/uploads/2019/04/LogoSantPau.png
756
756
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-02-01 14:04:192023-07-28 14:04:3401/02/22 – ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner
https://amr-accelerator.eu/wp-content/uploads/2023/07/Uni-Oxford-UCL.png
2000
2000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-11-02 13:50:102023-07-28 13:50:2102/11/21 – Antibiotic Research UK awards grants to fund research worth £200,000